Droxinavir (SC-55389A) free base is an HIV-1 protease inhibitor and antiviral agent. Droxinavir binds to the S2 and S2 subsites of HIV-1 protease, and this interaction is regulated by protease amino acid residue 88, where the N88S mutation confers viral resistance. Droxinavir can be used in studies related to human immunodeficiency virus type 1 infection[1].
Molekulargewicht:
533.75
CAS Nummer:
[159910-86-8]
Formel:
C29H51N5O4
Target-Kategorie:
HIV,HIV Protease
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
